Emerging Infectious Diseases

Journal Title：Emerging Infectious Diseases

Emerging Infectious Diseases is an open-access, peer-reviewed journal published monthly by the Centers for Disease Control and Prevention (CDC). Note that beginning with Volume 26, the journal began publishing online-only. Publication in EID enables compliance with the NIH Public Access Policy.

Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes.

The conclusions, findings, and opinions expressed by authors contributing to Emerging Infectious Diseases do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.

《新发传染病》是一份开放获取、同行评审的期刊，由美国疾病控制与预防中心 (CDC) 每月出版。请注意，从第 26 卷开始，该期刊开始仅在线出版。在 EID 上出版符合 NIH 公共访问政策。

《新发传染病》遵循国际医学期刊编辑委员会关于在医学期刊上开展、报告、编辑和出版学术工作的建议。该期刊的同行评审流程允许通常不属于其编辑人员的专家对提交的稿件进行批判性评估。作为独立出版物，该期刊的同行评审流程独立于 CDC 的审批流程。

《新发传染病》作者所表达的结论、发现和观点不一定反映美国卫生与公众服务部、公共卫生服务部、疾病控制与预防中心或作者所属机构的官方立场。使用商标名仅用于识别，并不意味着获得美国公共卫生服务部或美国卫生与公众服务部的认可。

Emerging Infectious Diseases创刊于1995年，由Centers for Disease Control and Prevention (CDC)出版商出版，收稿方向涵盖医学 - 传染病学全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 约1.0个月 ，影响因子指数7.2，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。